StockData
HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF

HUTCHMED (China) Ltd

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 5, 2026
$14.18+0.13 (+0.93%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
27.3
Dividend yield
–

HUTCHMED (China) statistics

Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison

Valuation

MeasureHUTCHMED (China)Industry median
Market Cap$2.47B$166.30M
Enterprise Value$1.23B$88.19M
PE Ratio5.4520.44
PS Ratio4.513.65
PB Ratio1.962.03
P/TBV Ratio1.972.29

Enterprise value

MeasureHUTCHMED (China)Industry median
EV / Sales2.242.51

Income (trailing twelve months)

MeasureHUTCHMED (China)Industry median
Revenue$548.51M$58.34M
Gross Profit$212.16M$105.94M
Operating Income-$39.16M-$21.40M
Pretax Income$498.69M-$14.34M
Net Income$456.91M-$22.46M
EBITDA-$25.85M-$16.91M
EPS (Diluted)$0.52-$0.83

Margins

MeasureHUTCHMED (China)Industry median
Gross Margin38.7%52.9%
Operating Margin-7.14%-44.0%
Pretax Margin90.9%-13.3%
Profit Margin83.3%-40.2%
EBITDA Margin-4.71%-30.2%
FCF Margin-14.4%-9.27%

Returns

MeasureHUTCHMED (China)Industry median
Return on Equity (ROE)36.7%-53.2%
Return on Assets (ROA)26.0%-40.9%
Return on Capital Employed (ROCE)-2.68%-38.1%

Growth

MeasureHUTCHMED (China)Industry median
Revenue Growth (YoY)-13.0%5.96%
Net Income Growth (YoY)1111.0%-35.2%
EPS Growth (YoY)1200.0%-26.2%
Revenue Growth (3Y CAGR)8.76%2.25%
Revenue Growth (5Y CAGR)19.2%6.48%

Balance sheet

MeasureHUTCHMED (China)Industry median
Cash & Short-Term Investments$1.37B$61.43M
Total Debt$116.91M$118.52M
Net Cash (Debt)$1.26B$15.35M
Net Cash Per Share$1.44$0.66
Equity (Book Value)$1.26B$49.09M
Book Value Per Share$1.45$1.37
Tangible Book Value$1.26B$23.52M
Working Capital$1.28B$76.81M

Financial position

MeasureHUTCHMED (China)Industry median
Current Ratio5.643.34
Quick Ratio5.422.44
Debt / Equity0.090.52
Interest Coverage-13.67-6.26

Cash flow (trailing twelve months)

MeasureHUTCHMED (China)Industry median
Operating Cash Flow-$64.66M-$12.35M
Capital Expenditures-$14.15M-$1.08M
Free Cash Flow-$78.81M-$20.22M
FCF Per Share-$0.09-$0.42

Efficiency

MeasureHUTCHMED (China)Industry median
Asset Turnover0.310.39
Inventory Turnover7.532.70
Revenue Per Employee$5.03M$404.87K
Profits Per Employee$4.19M-$703.34K
Employee Count10974

Dividends and yields

MeasureHUTCHMED (China)Industry median
Earnings Yield18.5%-23.3%
FCF Yield-3.19%-8.72%
Buyback Yield-0.06%-0.59%
Shareholder Yield-0.06%0.00%

Shares

MeasureHUTCHMED (China)Industry median
Shares Outstanding872,328,00058,127,000
Shares Change (YoY)0.01%10.9%
Float868,522,00049,136,700
Shares Held by Insiders0.44%11.6%
Shares Held by Institutions0.51%59.4%

Taxes

MeasureHUTCHMED (China)Industry median
Income Tax$63.61M$79.87K
Effective Tax Rate12.8%20.6%

Scores

MeasureHUTCHMED (China)Industry median
Graham Number$4.11$18.73
Graham Upside45.0%-45.1%
Altman Z-Score4.05-0.22
Piotroski F-Score44

Calculated by StockData from HUTCHMED (China)'s SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.